L-Arginine-N-FMOC PBF-OH-¹³C₆

Cat. No.: HY-Y1636S1: FAQs
Data Sheet Handling Instructions

Molarity Calculator

L-Arginine-N-FMOC PBF-OH-¹³C₆ is the ¹³C labeled Fmoc-Arg(Pbf)-OH[1]. Fmoc-Arg(Pbf)-OH is an arginine derivative containing amine protecting group Fmoc. Fmoc-Arg(Pbf)-OH is a building block for the introduction of Arg into SPPS (Solid-Phase Peptide Synthesis)[2].

For research use only. We do not sell to patients.

L-Arginine-N-FMOC PBF-OH-<sup>13</sup>C<sub>6</sub> Chemical Structure

L-Arginine-N-FMOC PBF-OH-¹³C₆ Chemical Structure

Size		Stock
50 mg		Get quote
100 mg		Get quote
250 mg		Get quote
Other size		Get quote

Synthetic products have potential research and development risk.

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Other Forms of L-Arginine-N-FMOC PBF-OH-¹³C₆:

Fmoc-Arg(Pbf)-OH In-stock

Featured Recommendations

•Related Small Molecules:

•Related Proteins:

Biological Activity
Purity & Documentation
References
Customer Review

Description	L-Arginine-N-FMOC PBF-OH-¹³C₆ is the ¹³C labeled Fmoc-Arg(Pbf)-OH[1]. Fmoc-Arg(Pbf)-OH is an arginine derivative containing amine protecting group Fmoc. Fmoc-Arg(Pbf)-OH is a building block for the introduction of Arg into SPPS (Solid-Phase Peptide Synthesis)[2].
In Vitro	Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs^[1]. MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. L-Arginine-N-FMOC PBF-OH-¹³C₆ Related Antibodies
Molecular Weight	654.72
Formula	C₂₈¹³C₆H₄₀N₄O₇S
SMILES	O=S(N[13C](N[13CH2][13CH2][13CH2][13C@@H]([13C](O)=O)NC(OCC1C2=CC=CC=C2C3=CC=CC=C31)=O)=N)(C4=C(C)C(C)=C5OC(C)(C)CC5=C4C)=O
Shipping	Room temperature in continental US; may vary elsewhere.
Storage	Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation	Data Sheet (266 KB) Handling Instructions (2659 KB)
References	[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216. [Content Brief] [2]. Beatriz G, et al. Successful development of a method for the incorporation of Fmoc-Arg (Pbf)-OH in solid-phase peptide synthesis using N-butylpyrrolidinone (NBP) as solvent. Green Chemistry, 2020, 22(10): 3162-3169.